COSMETIC COMPOSITOIN CONTAINING A RUBUS COREANUS EXTRACT FOR DIMINISHING SKIN WRINKLES
This application is a divisional of application Ser. No. 13/381,784 filed Dec. 30, 2011, which in is a U.S. national phase of International Application No. PCT/KR2010/004144 filed 25 Jun. 2010 which designated the U.S. and claims priority to KR 10-2009-0058901 filed 30 Jun. 2009, the entire contents of each of which are hereby incorporated by reference. The present invention relates to a cosmetic composition containing a Generally, for the release of a neurotransmitter, a synaptic vesicle containing the neurotransmitter is required to be fused with a presynaptic membrane so that a passage between two boundaries can be formed. Herein, a fundamental force for such membrane fusion is provided by SNARE complexes comprising three kinds of proteins. Particularly, when a release passage of a neurotransmitter is generated by membrane fusion between a synaptic vesicle and a presynaptic membrane, a t-SNARE complex (a complex of a syntaxin-1a protein, and a SNAP-25 protein) attached to a target membrane forms a parallel coiled with a v-SNARE attached to a vesicle. Such SNARE proteins are twisted in a spiral shape. In the membrane fusion, rearrangement of a lipid bilayer, which is widely known in the art, occurs. Since biomembranes strongly repel against each other, the membranes cannot be automatically merged, and thus a strong external force is required to overcome the repulsive force between the membranes. Herein, SNARE proteins generate such a strong force enough to overcome the repulsive force between the membranes. In other words, the formation of a SNARE complex is a force generator to overcome a repulsive power between membranes, and a main action in exocytosis including release of a neurotransmitter. Meanwhile, a neuromuscular junction in the upper layer of muscles acts to regulate the relaxation and constriction of muscles, and the nerve terminal is filled with synaptic vesicles. BoNT (Botulinum neurotoxin; hereinafter referred to as “Botox”) is a protease for cleavage of a SNARE protein, which is a main protein involved in the release of a neurotransmitter. Botox cleaves a SNARE protein to block neurotransmission, which results in paralysis of Botox-penetrated muscle cells. Botox irreversibly cleaves the SNARE protein to blocks neurotransmission, whereas so-called “applicable Botox” is a kind of competitive inhibitor that inhibits the formation of a SNARE complex to interfere with neurotransmission. Argireline that is the main component of an applicable botox product currently has disadvantages in that its effect is not reliable, its price is unfavorable due to the characteristics of the synthetic peptide and it is not consumer-friendly. Developing a neurotransmission inhibitor based on a natural extract can provide a raw material that is significantly inexpensive compared to a peptide material, and a final product produced from the natural extract is consumer-friendly. Thus, the natural extract is easily industrially applied compared to peptide materials. Meanwhile, a medicinal herb processing technique that is a traditional oriental medicine manufacturing technique is called “Po-je”, “Hap-hwa”, “Hap-yak”, “Su-chi”, “Po-ja”, “Beob-je” and “Su-sa” in Korean. This technique can be defined as a medicine manufacturing technique of changing the inherent properties of medicinal herbs by processing the medicinal herbs on the basis of the oriental medicine theory. The processing of medicinal herbs includes selection of correct medicine, removal of impurities, purification, heating, processing employing aids, etc. In some cases, medicinal herbs are processed together with aids suitable for medical applications in order to achieve the administration of medicine according to disease. Because various aids are used in the processing of medicinal herbs, they have different properties and effects, and thus the processed medicinal herbs show different effects. Aids which are currently used in the processing of medicinal herbs are various and broadly divided into liquid aids and solid aids. The liquid aids include liquor, vinegar, brine, honey, ginger juice, licorice juice, black bean juice, saline solution, rice water, horse oil, milk, children urine, and lime water. The solid aids include rice, wheat bran, alum, bean-curd, soil, seashell powder, and sand. The processing medicinal herbs is carried out to clarify medicines, facilitate the storage of medicines, reduce or remove the toxicity or side effects of medicines, change the properties of medicines to make the medicines more effective, enhance the therapeutic effects of medicines, and the offensive odor and taste of medicines to facilitate the intake of the medicines. Skin wrinkles are the most noticeable sign of skin aging which occurs due to intrinsic factors, such as aging and stress, or external environmental factors such as air pollution and UV radiation. Wrinkles occur on facial areas, such as the forehead, eye rims, eyebrow, and peri-oral areas, and various portions of the body, such as a neck, neck circumferences, elbows, armpits, hands, and feet. Wrinkles generally start to become visible after about 30 years old, and the number or depth thereof increase with aging. Such wrinkles are considered to occur mainly because reactive oxygen species produced in skin tissues by a skin aging crosslink collagen fibers and elastic fibers forming the majority of the skin dermis to change the production and degradation of such fibers. Antioxidants such as vitamin E, beta-carotene, vitamin C and glutathione, which are used to inhibit skin aging, radical scavengers, or substances such as vitamin A, which increase the synthesis of dermal collagen, have been used to reduce skin wrinkles. However, such cosmetic active ingredients have disadvantages in that they are mostly strongly irritating to the skin or are unstable in formulations to cause discoloration, bad smell and precipitation, and the inherent activity thereof decreases. Recently, in order to reduce skin irritation of various chemicals, various cosmetics based on natural materials have been developed. Such natural materials have reduced adverse effects on the skin and also have high consumer preference, and thus their value as cosmetic materials is gradually increasing. Accordingly, the present inventors have conducted studies on natural materials having an excellent effect of reducing skin wrinkles and, as a result, have found that a cosmetic composition comprising a It is, therefore, an object of the present invention to provide a cosmetic composition containing a To achieve the above object, the present invention provides a cosmetic composition containing a The cosmetic composition according to the present invention contains as an active ingredient a The present invention provides a composition for reducing skin wrinkles which contains a Hereinafter, the present invention will be described in detail. The In order to prepare the Also, In the present invention, extraction of Examples of an organic solvent that may be used in the present invention include ethanol, methanol, butanol, ether, ethyl acetate, chloroform, and a mixed solvent of at least one thereof with water. Preferably, 80% ethanol is used. The extraction process is preferably carried out at a temperature of 10˜80° C. for 6-24 hours. If the extraction temperature and time are out of these ranges, the efficiency of extraction will be insufficient or the components of After the extract has been obtained using the solvent, it may be macerated at room temperature, heated and filtered, according to a conventional method in the art, thus obtaining a liquid material. Alternatively, it may be evaporated to remove the solvent or may be spray-dried or freeze-dried. The cosmetic composition according to the present invention contains the The cosmetic composition according to the present invention may be formulated into, but not limited to, skin lotion, astringent lotion, milk lotion, nourishing cream, massage cream, essence, pack, foundation, lipstick or powder foundation. Components other than the extract in the cosmetic composition of the present invention can be suitably selected without difficulty by a person skilled in the art depending on the formulation or intended use of the cosmetic composition. Hereinafter, the present invention will be described in further detail with reference to examples and test examples. It is to be understood, however, that these examples are for illustrative purposes only and are not to be construed to limit the scope of the present invention. 1 kg of dried 1 kg of dried 1 kg of dried 1 kg of dried The membrane fusion inhibitory effects of the The membrane fusion inhibition (%) of each of the As can be seen in Table 1 above, the groups treated with the PC12 cells were cultured in Ham's F12K medium, containing 10% fetal calf serum, 5% fetal bovine serum and antibiotics, in a collagen-coated plate (60 mm dish). For subculture, the medium was sucked from the culture plate, after which 2 ml of PBS was added to the culture plate, and the cells were isolated from the dish wall by pipetting and centrifuged at 1,000×g for 5 minutes. The cells were harvested, fresh medium was added thereto, and the cell pellets were dispersed by pipetting, added to a fresh culture plate and incubated in an incubator at 37 in the presence of 5% CO2 gas. [3H]-noradrenaline used in the test was purchased from Amersham. The medium was sucked from the PC12 cell culture plate, PBS was added to the culture plate, and the cells were detached from the plate wall, after which the number of the cells was counted with a hemacytometer. Then, the cells were dispersed and inoculated in fresh medium at a concentration of 2×105 cells/ml. After 24 hours, noradrenaline calibration buffer ([3H]-NA, 1.5 μCi/ml) was added to the cells which were then incubated in a CO2 gas incubator for 90 minutes. After incubation, the buffer was removed, after which the cells were washed three times with PBS. Then, the cells were inoculated in fresh medium, and 10 μg/ml of each of As can be seen in Hereinafter, formulation examples of the composition according to the present invention will be described, but the scope of the present invention is not limited thereto. A milk lotion containing an extract of wine-added steamed A skin lotion containing an extract of wine-added steamed A nourishing cream containing an extract of wine-added steamed A massage cream containing an extract of wine-added steamed A pack containing an extract of wine-added steamed The cosmetic composition of Formulation Example 3 containing the extract of wine-added steamed As can be seen in Tables 8 and 9, when the cosmetic composition containing the extract of wine-added steamed The present invention relates to a cosmetic composition containing a 1.-3. (canceled) 4. A method of reducing skin wrinkles comprising topically applying to affected skin a cosmetic composition containing an extract from 5. A method of inhibiting membrane fusion comprising topically applying to affected skin a cosmetic composition containing an extract from 6. A method of inhibiting release of a neurotransmitter in PC12 cells comprising topically applying to affected skin a cosmetic composition containing an extract from 7. A method of inhibiting the formation of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) comprising topically applying to affected skin a cosmetic composition containing an extract from TECHNICAL FIELD
BACKGROUND ART
Technical Problem
Technical Solution
Advantageous Effects
BRIEF DESCRIPTION OF DRAWINGS
BEST MODE
MODE FOR INVENTION
Example 1
Preparation of Extract of Raw
Example 2
Preparation of Extract of Roasted
Example 3
Preparation of Extract of Yellow Rice Wine-Added Steamed
Example 4
Preparation of Extract of Brine-Added Roasted
Test Example 1
Inhibitory Effect on Membrane Fusion
Membrane fusion inhibitory effects of extracts Sample Membrane fusion name inhibition (%) Control 100 Example 1 Extract of raw 51 Example 2 Extract of roasted 48 Example 3 Extract of wine-added, steamed 0 Example 4 Extract of saline-added, roasted 53 Test Example 2
Inhibitory Effect on the Release of a Neurotransmitter in PC12 Cells
Formulation Example 1
Milk Lotion
Example 3 5.0 Squalane 5.0 Beeswax 4.0 Polysorbate 60 1.5 Sorbitan sesquioleate 1.5 Liquid paraffin 0.5 Caprylic/capric triglyceride 5.0 Glycerin 3.0 Butylene glycol 3.0 Propylene glycol 3.0 Caboxylvinyl polymer 0.1 Triethanolamine 0.2 Preservative, pigment and fragrance q.s. Purified water balance Total 100 Formulation Example 2
Skin Lotion
Example 3 5.0 Glycerin 3.0 Butylene glycol 2.0 Propylene glycol 2.0 Caboxylvinyl polymer 0.1 PEG 12 nonylphenylether 0.2 Polysorbate 80 0.4 Ethanol 10.0 Triethanolamine 0.1 Preservative, pigment and fragrance q.s. Purified water balance Total 100 Formulation Example 3
Nourishing Cream
Example 3 5.0 Polysorbate 60 1.5 Sorbitan sesquioleate 0.5 PEG60 hydrogenated castor oil 2.0 Liquid paraffin 10.0 Squalane 5.0 Caprylic/capric triglyceride 5.0 Glycerin 5.0 Butylene glycol 3.0 Propylene glycol 3.0 Triethanolamine 0.2 Preservative, pigment and fragrance q.s. Purified water balance Total 100 Formulation Example 4
Massage Cream
Example 3 5.0 Beeswax 10.0 Polysorbate 60 1.5 Sorbitan sesquioleate 0.8 PEG60 hydrogenated castor oil 2.0 Liquid paraffin 40.0 Squalane 5.0 Caprylic/capric triglyceride 4.0 Glycerin 5.0 Butylene glycol 3.0 Propylene glycol 3.0 Triethanolamine 0.2 Preservative, pigment and fragrance q.s. Purified water balance Total 100 Formulation Example 4
Pack
Example 3 5.0 Polyvinyl alcohol 13.0 Sodium carboxymethylcellulose 0.2 Glycerin 5.0 Allantoin 0.1 Ethanol 6.0 PEG 12 nonylphenylether 0.3 Polysorbate 60 0.3 Preservative, pigment and fragrance q.s. Purified water balance Total 100 Test Example 3
Skin Wrinkle-Reducing Effect of a Cosmetic Composition Containing an Extract of Wine-Added steamed
Criteria for evaluation Criteria for evaluation of skin wrinkles Score Very severely increased −3 Increased −2 Slightly increased −1 Not changed 0 Slightly reduced 1 Reduced 2 Very reduced 3 Objective evaluation by experts Degree of average reduction of wrinkles (ΔW) Subjects T0 T12 Subject 1 0 2 Subject 2 0 2 Subject 3 0 3 Subject 4 0 1 Subject 5 0 2 Subject 6 0 2 Subject 7 0 2 Subject 8 0 3 Subject 9 0 1 Subject 10 0 3 ΔW (T12-T0) 2.1 Subjective evaluation by subjects Degree of average reduction of wrinkles (ΔW) Subjects T0 T12 Subject 1 0 2 Subject 2 0 3 Subject 3 0 3 Subject 4 0 2 Subject 5 0 2 Subject 6 0 2 Subject 7 0 2 Subject 8 0 2 Subject 9 0 1 Subject 10 0 3 ΔW (T12-T0) 2.0
